Adriana Uchôa

Prof. Dr. Adriana Uchôa

Instituto de Medicina Tropical do Rio Grande do Norte
+2
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRichele J. A. Machado
Richele J. A. Machado
NMNorberto K. V. Monteiro
Norberto K. V. Monteiro
Ludovico MiglioloLudovico Migliolo
Ludovico Migliolo
OSOsmar Nascimento Silva
Osmar Nascimento Silva
MPMichele F. S. Pinto
Michele F. S. Pinto
ESElizeu Santos
Elizeu Santos
Inhibitors of peptidases isolated from leguminous seeds have been studied for their pharmacological properties. The present study focused on purification, biochemical characterization and anti-inflammatory and anticoagulant evaluation of a novel Kunitz trypsin inhibitor from Erythrina velutina seeds (EvTI). Trypsin inhibitors were purified by ammonium sulfate (30–60%), fractionation followed by Trypsin-Sepharose affinity chromatography and reversed-phase high performance liquid chromatography. The purified inhibitor showed molecular mass of 19,210.48 Da. Furthermore, a second isoform with 19,228.16 Da was also observed. The inhibitor that showed highest trypsin specificity and enhanced recovery yield was named EvTI (P2) and was selected for further analysis. The EvTI peptide fragments, generated by trypsin and pepsin digestion, were further analyzed by MALDI-ToF-ToF mass spectrometry, allowing a partial primary structure elucidation. EvTI exhibited inhibitory activity against trypsin with IC50 of 2.2×10−8 mol.L−1 and constant inhibition (Ki) of 1.0×10−8 mol.L−1, by a non-competitive mechanism. In addition to inhibit the activity of trypsin, EvTI also inhibited factor Xa and neutrophil elastase, but do not inhibit thrombin, chymotrypsin or peptidase 3. EvTI was investigated for its anti-inflammatory and anti-coagulant properties. Firstly, EvTI showed no cytotoxic effect on human peripheral blood cells. Nevertheless, the inhibitor was able to prolong the clotting time in a dose-dependent manner by using in vitro and in vivo models. Due to anti-inflammatory and anticoagulant EvTI properties, two sepsis models were here challenged. EvTI inhibited leukocyte migration and specifically acted by inhibiting TNF-α release and stimulating IFN-α and IL-12 synthesis. The data presented clearly contribute to a better understanding of the use of Kunitz inhibitors in sepsis as a bioactive agent capable of interfering in blood coagulation and inflammation.

28 March 2012 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LRLuciana Rabelo
Luciana Rabelo
NMNorberto Monteiro
Norberto Monteiro
RSRaphael Serquiz
Raphael Serquiz
PSPaula Medeiros Santos
Paula Medeiros Santos
RORuth Oliveira
Ruth Oliveira
ESElizeu Santos
Elizeu Santos
Cancer represents a set of more than 100 diseases, including malignant tumors from different locations. Strategies inducing differentiation have had limited success in the treatment of established cancers. Marine sponges are a biological reservoir of bioactive molecules, especially lectins. Several animal and plant lectins were purified with antitumor activity, mitogenic, anti-inflammatory and antiviral, but there are few reports in the literature describing the mechanism of action of lectins purified from marine sponges to induce apoptosis in human tumor cells. In this work, a lectin purified from the marine sponge Cinachyrella apion (CaL) was evaluated with respect to its hemolytic, cytotoxic and antiproliferative properties, besides the ability to induce cell death in tumor cells. The antiproliferative activity of CaL was tested against HeLa, PC3 and 3T3 cell lines, with highest growth inhibition for HeLa, reducing cell growth at a dose dependent manner (0.5–10 µg/mL). Hemolytic activity and toxicity against peripheral blood cells were tested using the concentration of IC50 (10 µg/mL) for both trials and twice the IC50 for analysis in flow cytometry, indicating that CaL is not toxic to these cells. To assess the mechanism of cell death caused by CaL in HeLa cells, we performed flow cytometry and western blotting. Results showed that lectin probably induces cell death by apoptosis activation by pro-apoptotic protein Bax, promoting mitochondrial membrane permeabilization, cell cycle arrest in S phase and acting as both dependent and/or independent of caspases pathway. These results indicate the potential of CaL in studies of medicine for treating cancer.

27 September 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
FCFabiana M. C. Carvalho
Fabiana M. C. Carvalho
VLVanessa C. O. Lima
Vanessa C. O. Lima
ICIzael S. Costa
Izael S. Costa
AMAmanda de Medeiros
Amanda de Medeiros
ASAlexandre Serquiz
Alexandre Serquiz
AMAna Morais
Ana Morais
Trypsin inhibitors are studied in a variety of models for their anti-obesity and anti-inflammatory bioactive properties. Our group has previously demonstrated the satietogenic effect of tamarind seed trypsin inhibitors (TTI) in eutrophic mouse models and anti-inflammatory effects of other trypsin inhibitors. In this study, we evaluated TTI effect upon satiety, biochemical and inflammatory parameters in an experimental model of metabolic syndrome (MetS). Three groups of n = 5 male Wistar rats with obesity-based MetS received for 10 days one of the following: (1) Cafeteria diet; (2) Cafeteria diet + TTI (25 mg/kg); and (3) Standard diet. TTI reduced food intake in animals with MetS. Nevertheless, weight gain was not different between studied groups. Dyslipidemia parameters were not different with the use of TTI, only the group receiving standard diet showed lower very low density lipoprotein (VLDL) and triglycerides (TG) (Kruskal–Wallis, p < 0.05). Interleukin-6 (IL-6) production did not differ between groups. Interestingly, tumor necrosis factor-alpha (TNF-α) was lower in animals receiving TTI. Our results corroborate the satietogenic effect of TTI in a MetS model. Furthermore, we showed that TTI added to a cafeteria diet may decrease inflammation regardless of weight loss. This puts TTI as a candidate for studies to test its effectiveness as an adjuvant in MetS treatment.

1 February 2015 in Clinics
Verified
Journal Article
Open access
JRJoycellane Alline Do Nascimento Campos Ribeiro
Joycellane Alline Do Nascimento Campos Ribeiro
ASAlexandre Coellho Serquiz
Alexandre Coellho Serquiz
PSPriscila Fabíola Dos Santos Silva
Priscila Fabíola Dos Santos Silva
PBPatrícia Batista Barra Medeiros Barbosa
Patrícia Batista Barra Medeiros Barbosa
TSTarcísio Bruno Montenegro Sampaio
Tarcísio Bruno Montenegro Sampaio
AMAna Morais
Ana Morais
Seeds are excellent sources of proteinase inhibitors, some of which may have satietogenic and slimming actions. We evaluated the effect of a trypsin inhibitor from Tamarindus indica L. seeds on weight gain, food consumption and cholecystokinin levels in Wistar rats. A trypsin inhibitor from Tamarindus was isolated using ammonium sulfate (30-60%) following precipitation with acetone and was further isolated with Trypsin-Sepharose affinity chromatography. Analyses were conducted to assess the in vivo digestibility, food intake, body weight evolution and cholecystokinin levels in Wistar rats. Histological analyses of organs and biochemical analyses of sera were performed. The trypsin inhibitor from Tamarindus reduced food consumption, thereby reducing weight gain. The in vivo true digestibility was not significantly different between the control and Tamarindus trypsin inhibitor-treated groups. The trypsin inhibitor from Tamarindus did not cause alterations in biochemical parameters or liver, stomach, intestine or pancreas histology. Rats treated with the trypsin inhibitor showed significantly elevated cholecystokinin levels compared with animals receiving casein or water. The results indicate that the isolated trypsin inhibitor from Tamarindus reduces weight gain by reducing food consumption, an effect that may be mediated by increased cholecystokinin. Thus, the potential use of this trypsin inhibitor in obesity prevention and/or treatment should be evaluated.

24 July 2014 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
PBPatrícia Batista Barra Medeiros Barbosa
Patrícia Batista Barra Medeiros Barbosa
JOJulliete Medeiros de Oliveira
Julliete Medeiros de Oliveira
JCJuliana Macêdo Chagas
Juliana Macêdo Chagas
LRLuciana Rabelo
Luciana Rabelo
GMGuilherme Fulgêncio de Medeiros
Guilherme Fulgêncio de Medeiros
MXMARIA DE FÁTIMA FREIRE DE MELO XIMENES
MARIA DE FÁTIMA FREIRE DE MELO XIMENES

1 March 2010 in Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
DMDanielle S. Medeiros
Danielle S. Medeiros
TMThales L. Medeiros
Thales L. Medeiros
JRJannison K.C. Ribeiro
Jannison K.C. Ribeiro
NMNorberto K.V. Monteiro
Norberto K.V. Monteiro
Ludovico MiglioloLudovico Migliolo
Ludovico Migliolo
ESElizeu Santos
Elizeu Santos